Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.

Journal: Journal of the International AIDS Society

Volume: 22

Issue: 8

Year of Publication: 2020

Affiliated Institutions:  Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland. Department of Drug and Infectious Diseases Epidemiology, National Institute for Health Development, Tallinn, Estonia. Division of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland. Division of Infectious Diseases, University Hospital Geneva, University of Geneva, Geneva, Switzerland. Division of Infectious Diseases, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland. Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Aarau, Switzerland. Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland. Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerland. Department of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland. Institute of Global Health, University of Geneva, Geneva, Switzerland.

Abstract summary 

In many countries, mortality due to suicide is higher among people living with HIV than in the general population. We aimed to analyse trends in suicide mortality before and after the introduction of triple combination antiretroviral therapy (cART), and to identify risk factors associated with death from suicide in Switzerland.We analysed data from the Swiss HIV Cohort Study from the pre-cART (1988-1995), earlier cART (1996-2008) and later cART (2009-2017) eras. We used multivariable Cox regression to assess risk factors for death due to suicide in the ART era and computed standardized mortality ratios (SMRs) to compare mortality rates due to suicide among persons living with HIV with the general population living in Switzerland, using data from the Swiss National Cohort.We included 20,136 persons living with HIV, of whom 204 (1.0%) died by suicide. In men, SMRs for suicide declined from 12.9 (95% CI 10.4-16.0) in the pre-cART era to 2.4 (95% CI 1.2-5.1) in the earlier cART and 3.1 (95% CI 2.3-4.3) in the later cART era. In women, the corresponding ratios declined from 14.2 (95% CI 7.9-25.7) to 10.2 (3.8-27.1) and to 3.3 (95% CI 1.5-7.4). Factors associated with death due to suicide included gender (adjusted hazard ratio 0.58 (95% CI 0.38-0.87) comparing women with men), nationality (1.95 (95% CI 1.34-2.83) comparing Swiss with other), Centers for Disease Control and Prevention clinical stage (0.33 (95% CI 0.24-0.46) comparing stage A with C), transmission group (2.64 (95% CI 1.71-4.09) for injection drug use and 2.10 (95% CI 1.36-3.24) for sex between men compared to other), and mental health (2.32 (95% CI 1.71-3.14) for a history of psychiatric treatment vs. no history). There was no association with age.Suicide rates have decreased substantially among people living with HIV in the last three decades but have remained about three times higher than in the general population since the introduction of cART. Continued emphasis on suicide prevention among men and women living with HIV is important.

Authors & Co-authors:  Ruffieux Yann Y Lemsalu Liis L Aebi-Popp Karoline K Calmy Alexandra A Cavassini Matthias M Fux Christoph A CA Günthard Huldrych F HF Marzolini Catia C Scherrer Alexandra A Vernazza Pietro P Keiser Olivia O Egger Matthias M

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Lampe F, Miners A, Kreif N, Miltz A, Phillips A, Sewell J, et al. Comparison of depression and anxiety between HIV‐positive and HIV‐negative people. In: 22nd International AIDS conference. Amsterdam; 2018. p. Abstract 9417.
Authors :  13
Identifiers
Doi : e25339
SSN : 1758-2652
Study Population
Men,Women
Mesh Terms
Adult
Other Terms
HIV;SMR;Switzerland;comparative study;intravenous drug use;suicide
Study Design
Cohort Study,Case Control Trial,Cross Sectional Study
Study Approach
Country of Study
Publication Country
Switzerland